Startseite Podcasts ESO Voice of Stroke

ESO Voice of Stroke

European Stroke Organisation 6 Folgen Jun 23, 2026

Voice of Stroke is a podcast by the European Stroke Organisation that provides monthly updates on stroke research. Each episode highlights key papers from leading medical journals and discusses their implications for clinical practice. The show offers concise, evidence-based takeaways from breakthrough trials and cross-disciplinary insights.

Folgen

Blood Pressure Control: Which Patients May Benefit Most From Specific Strategies? Jun 23, 2026 12:08 How should clinicians think about hypertension in 2026? In this episode of Voice of Stroke, we explore recent evidence addressing one of the most important questions in vascular prevention: not simply whether to lower blood pressure, but which treatments work best, who should be treated, and how hypertension-related vascular disease may influence stroke mechanisms and secondary prevention. This ep

Intracerebral Haemorrhage – From Blood Pressure Control to Secondary Brain Injury Mai 28, 2026 12:33 In this episode of Voice of Stroke we explore major recent advances in intracerebral haemorrhage research. This episode discusses: The TRIDENT trial and long-term blood pressure lowering after ICH Perihaematomal oedema growth as a biomarker of secondary brain injury Translational neuroimmunology and inflammatory signalling after haemorrhage Highlights from the ESO ICH Academy Meeting in Maa

Atrial Fibrillation and Stroke Prevention – What's New? Apr 23, 2026 10:34 In this episode of Voice of Stroke, we explore the latest evidence shaping stroke prevention in atrial fibrillation (AF) – a condition responsible for up to a quarter of all ischaemic strokes. This episode examines emerging strategies and unresolved questions in AF management, including: Whether left atrial appendage closure (LAAC) can replace anticoagulation in patients eligible for oral therap

What's new in the field of lipids, and can it help us prevent stroke? Mär 24, 2026 10:12 In this episode of Voice of Stroke, we explore new evidence shaping how lipid management can reduce stroke risk across both primary and secondary prevention. This episode explores: Reassessing statin side effects using large-scale randomised trial data The role of PCSK9 inhibition (VESALIUS-CV) in reducing vascular events in high-risk patients without prior stroke Long-term data linking

Beyond the Window – What ISC 2026 Tells Us About Treating Stroke Earlier or Later Feb 24, 2026 10:01 In this first episode of Voice of Stroke, we examine three key trials presented at ISC 2026 that challenge how we define time boundaries in acute stroke care. This episode explores: · Extending intravenous thrombolysis beyond 4.5 hours in non-large vessel occlusion stroke (OPTION) · Tenecteplase within 24 hours for basilar artery occlusion (TRACE-5) · Ultra-early recombinant f

Welcome to the Voice of Stroke Podcast Feb 9, 2026 50 Welcome to Voice of Stroke, brought to you by the European Stroke Organisation. Your fast, reliable update on the science driving stroke care forward. Each month, we spotlight key papers from the world's leading journals and discuss how it can inform and refine clinical practice. From breakthrough randomised controlled trials to cross-disciplinary insights, Voice of Stroke brings you concise, evid